HomeLCTX • NYSEAMERICAN
Lineage Cell Therapeutics Inc
$1.20
After Hours:
$1.20
(0.00%)0.00
Closed: Apr 18, 4:09:01 PM GMT-4 · USD · NYSEAMERICAN · Disclaimer
StockUS listed security
Previous close
$1.29
Day range
$1.18 - $1.30
Year range
$0.84 - $1.61
Market cap
226.24M USD
Avg Volume
1.16M
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
(USD)Dec 2023Y/Y change
Revenue
2.09M9.03%
Operating expense
4.66M-44.82%
Net income
-4.78M24.85%
Net profit margin
-228.6931.08%
Earnings per share
-0.031.31%
EBITDA
-2.66M58.91%
Effective tax rate
0.00%
Total assets
Total liabilities
(USD)Dec 2023Y/Y change
Cash and short-term investments
35.49M-38.67%
Total assets
101.02M-18.31%
Total liabilities
39.00M-24.61%
Total equity
62.02M
Shares outstanding
188.53M
Price to book
3.58
Return on assets
-6.83%
Return on capital
-10.51%
Net change in cash
(USD)Dec 2023Y/Y change
Net income
-4.78M24.85%
Cash from operations
-6.02M27.51%
Cash from investing
9.74M290.94%
Cash from financing
-13.00K-110.66%
Net change in cash
3.99M129.88%
Free cash flow
707.00K109.94%
About
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Wikipedia
Founded
1990
Employees
72
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu